Literature DB >> 12823728

Inflammatory mediators in autotransfusion drain blood after knee arthroplasty, with and without leucocyte reduction.

T Dalén1, A Bengtsson, B Brorsson, K G Engström.   

Abstract

BACKGROUND AND OBJECTIVES: The aim of this study was to evaluate whether leucocyte-reducing filters influenced complement activation and the formation of pro-inflammatory cytokines in autotransfusion drain blood after knee arthroplasty.
MATERIALS AND METHODS: Twenty-three patients undergoing knee arthroplasty were divided into two groups. All patients were given salvage blood postoperatively. In Group A, a leucocyte filter was connected between the wound and the drain blood container. In Group B the drain blood was not leucocyte filtered. Complement split products and cytokines were analysed in circulating blood and in drain blood, together with blood-cellular differential counts.
RESULTS: Drain blood showed activation vs. venous blood, with elevated concentrations of C3a, SC5b-9, interleukin (IL)-6, IL-8, polymorphonuclear (PMN) elastase and tumour necrosis factor-alpha (TNF-alpha) (P<0.05 to P<0.001). The leucocyte filter reduced TNF-alpha (P<0.01), but triggered complement activation (P<0.05). Room-temperature incubation increased the concentration of IL-8 (P<0.01), which was seen in both venous and drain blood. The leucocyte filter prevented formation of IL-8 (P<0.01). In drain blood at 24 h the inflammatory reactions accelerated (P<0.05-0.001), although the filter reduced the leucocyte counts and TNF-alpha concentrations.
CONCLUSIONS: The leucocyte filter reduced IL-8 and TNF-alpha in drain blood, but at the same time triggered complement activation. Incubation affected the inflammatory spectrum of both drain blood and control venous blood, and the filtering reduced this activation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12823728     DOI: 10.1046/j.1423-0410.2003.00314.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  8 in total

Review 1.  Laboratory characteristics and clinical utility of post-operative cell salvage: washed or unwashed blood transfusion?

Authors:  Manuel Muñoz; Robert Slappendel; Dafydd Thomas
Journal:  Blood Transfus       Date:  2010-09-14       Impact factor: 3.443

2.  Washing and filtering of cell-salvaged blood - does it make autotransfusion safer?

Authors:  Gerhardt Konig; Jonathan H Waters
Journal:  Transfus Altern Transfus Med       Date:  2012-12-01

3.  Unwashed shed blood: should we transfuse it?

Authors:  Giancarlo Maria Liumbruno; Jonathan H Waters
Journal:  Blood Transfus       Date:  2011-04-20       Impact factor: 3.443

4.  Recommendations for the transfusion management of patients in the peri-operative period. III. The post-operative period.

Authors:  Giancarlo Maria Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossetti
Journal:  Blood Transfus       Date:  2011-04-20       Impact factor: 3.443

5.  The effect of salvaged blood on coagulation function as measured by thromboelastography.

Authors:  Gerhardt Konig; Mark H Yazer; Jonathan H Waters
Journal:  Transfusion       Date:  2012-08-31       Impact factor: 3.157

6.  Post-traumatic immunosuppression is reversed by anti-coagulated salvaged blood transfusion: deductions from studying immune status after knee arthroplasty.

Authors:  N Islam; M Whitehouse; S Mehendale; M Hall; J Tierney; E O'Connell; A Blom; G Bannister; J Hinde; R Ceredig; B A Bradley
Journal:  Clin Exp Immunol       Date:  2014-08       Impact factor: 4.330

Review 7.  Blood Management Strategies in Total Knee Arthroplasty.

Authors:  David Liu; Michael Dan; Sara Martinez Martos; Elaine Beller
Journal:  Knee Surg Relat Res       Date:  2016-08-25

8.  Post-operative auto-transfusion in total hip or knee arthroplasty: a meta-analysis of randomized controlled trials.

Authors:  Zhao Haien; Jiang Yong; Ma Baoan; Guo Mingjun; Fan Qingyu
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.